EU variations reform: electronic applications and database updates
Some changes won't need a variation. They'll need a database update.
Article 94 of the agreed directive text requires variation applications to be made electronically in EMA formats, lets some changes be made as updates of the MAH's information in a database, and leaves categories and procedures to Commission delegated acts. It builds on the 2025 revision of the Variations Regulation, which already brought annual Type IA updates, super-grouping and PACMPs.
Minor changes leave the variation system
Type IA variation
Database update
Variation applications are made electronically, and some changes can be made as updates of the MAH's information in a database. Which changes qualify is left to Commission delegated acts.
Electronic for every application, simpler for some changes
Database updates could take simple changes out of the variation procedure, and electronic-only submission affects every procedure at once. The detail depends on delegated acts still to come.
e-only
Variation applications for national MAs made electronically in EMA formats, unless the change is a database update
12mo
Window to notify a Type IA change after implementation through the annual update, in force since January 2025
Art. 94(4)
Categories, database update procedures, grouping conditions and exemptions are left to Commission delegated acts
From mixed procedures to an electronic operating model
Four shifts, each affecting a different part of your variation operations.
Submission format
Electronic formats widely used (eCTD, IRIS for centralised products), but national practice still varies.
Applications made electronically in EMA formats for all national MAs (Art. 94(1)).
Minor administrative changes
Administrative changes such as an MAH address change need a Type IA notification, usually through the annual update.
Variations may include updates by the MAH of its information held in a database (Art. 94(1) and (3)). Which changes qualify is set by delegated act.
Classification
Type IA, IB and II categories under Regulation (EC) No 1234/2008 and the Commission's classification guidelines.
Categories by risk, from changes with the highest potential impact to those with none or minimal impact and administrative changes; procedures proportionate to risk (Art. 94(2) and (3)).
Grouping, worksharing and PACMPs
Since January 2025: super-grouping across MAs, wider worksharing, and PACMPs introduced by Type II variation.
Delegated acts set conditions for one application covering several changes or several MAs (Art. 94(4)(c)). PACMPs continue under the variations rules.
The agreed text is not yet published in the Official Journal. Application dates will be fixed by the published act.
Plan variations under both sets of rules
Workbench answers classification questions under today's categories and Art. 94. Alerts catches EMA and national notices on formats and procedures, and Fee Calculation estimates what each filing will cost.
What's up next?We file around 300 Type IA variations a year, mostly address changes and minor document updates. Under the new directive, will we still need to file them as variations?
- understanding your question…
Variations · current rules against the agreed text
- Based on the agreed text, which is not yet in the Official Journal. Dates count from entry into force.
1. Short answer
Not necessarily. Some changes can become database updates by the MAH, but which ones is left to Commission delegated acts, so there is no list yet. Applications for national MAs also go electronic in EMA formats.
2. What changes
3. What to do now
- Sort this year's Type IA changes into administrative and other changes.
- Keep using the annual Type IA update until the new rules apply.
- Revisit your variation SOPs once the delegated acts are adopted.
Workbench
Answers classification questions under the current categories and Art. 94, compares change filings, and asks which procedure a product went through when the answer depends on it.
See WorkbenchAlerts
Watches EMA and national authorities for variation guidance, electronic format notices and procedural updates, and matches each one to the licences it affects, with the notice cited.
See AlertsFee Calculation
Estimates the agency fees for a variation by procedure, RMS and CMS markets and strengths, in local currencies with payment terms and official references.
See Fee CalculationA 30-minute live walkthrough of Atlas, Alerts and Workbench, on your own products and markets
Part of the variations reform already applies
The 2025 revision already eased the workload. Electronic-only submission and database updates go further, but only for teams equipped to use them.
2025
Revised Variations Regulation applies from 1 January: annual Type IA update, super-grouping and PACMPs
Delegated Regulation (EU) 2024/1701
90 days
Assessment period a reference authority can apply to certain grouped variations under the 2025 revision
Delegated Regulation (EU) 2024/1701
Art. 94(4)(d)
Delegated acts can exempt updates of certain MA information from variation procedures altogether
Agreed directive text
What RA teams are asking about the variation reform
Which changes qualify for a database update instead of Type IA?
The agreed text leaves this to Commission delegated acts (Art. 94(4)), so there is no official list yet. Administrative data such as company name and address are the obvious candidates. Until then, Workbench can tell you which current category a change falls into, citing the Commission's classification guidelines.
How does the annual notification for Type IA changes work?
It is already in place: since 1 January 2025, most Type IA changes are notified within 12 months of implementation through an annual update, and super-grouping lets one notification cover several MAs of the same holder.
What is a PACMP and when should we use one?
A Post-Approval Change Management Protocol agrees in advance how a programme of connected changes will be assessed. Since January 2025 the Variations Regulation provides for introducing one by Type II variation; the implementing changes then typically fall into a lower category. Most valuable for iterative manufacturing, formulation and packaging change programmes.
Does electronic-only affect nationally authorised products?
Yes. The agreed text requires electronic applications in EMA formats for national MAs once the directive applies, 24 months after entry into force under the agreed text. Each national authority needs matching capability. Alerts watches national authorities for notices about their submission systems.
What happens to variations in progress at transition?
Procedures started under current rules finish under them. Changes submitted after the new rules apply should follow the new categories once the delegated acts exist. Expect a period where both frameworks run in parallel.
Related reading
- Variation workload across products is planned through regulatory lifecycle planning.
- MA records that variations change are kept current in licence portfolio management in Atlas.
- The highest-impact category is explained in the glossary entry on the Type II variation.
- Safety-driven variations often follow from periodic safety update reports (PSURs).
- Variations are one of ten changes covered in our guide to the new EU pharmaceutical directive.
- Dates that depend on publication are tracked on the EU pharma package legislative timeline.
Sources
Article numbers refer to the Council's position at first reading of 28 September 2026 (ST 7106/2/26 REV 2 for the directive, ST 7105/2/26 REV 2 for the regulation), which reflects the political agreement of December 2025. Numbering may change in the act published in the Official Journal.
- Council of the EU: Directive on the Union code relating to medicinal products for human use, Council position at first reading, 28 September 2026 (ST 7106/2/26 REV 2), Articles 94 and 95
- EUR-Lex: Commission Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations
- EUR-Lex: Commission Delegated Regulation (EU) 2024/1701 amending Regulation (EC) No 1234/2008 (applies from 1 January 2025)
- European Medicines Agency: Variations including extensions of marketing authorisations
- Council of the EU: 'Pharma package': Council and Parliament reach a deal (press release, 11 December 2025)
- Council of the EU: The pharma package, new EU rules on medicines (policy page)
- European Commission: Reform of the EU pharmaceutical legislation
- EUR-Lex: Procedure 2023/0132/COD, Directive on the Union code relating to medicinal products for human use (COM(2023) 192)
- EUR-Lex: Procedure 2023/0131/COD, Regulation on Union procedures for the authorisation and supervision of medicinal products (COM(2023) 193)
Get your variation processes ready before Art. 94 applies
SOPs and trackers built around Type IA, IB and II will need revisiting once the delegated acts set the new categories. Start with the administrative changes that could become database updates.
Book a variations walkthrough
30 minutes on your own portfolio: which changes could become database updates, and how Workbench, Alerts and Fee Calculation fit your variation work.
Book a demoAsk Workbench yourself
Put your variation questions to Workbench and get answers that cite the agreed text and the classification guidelines.
Try for free